IP Library Granted Patent US 7,838,716
Granted Patent B2
US 7,838,716 · App. 11/891,660 · Granted Nov 23, 2010

High speed swelling, pressure exerting hemostatic device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,838,716
App. No.
11/891,660
Granted
Nov 23, 2010
Kind
B2
Abstract

The present invention provides devices and methods for treating wounds. The devices may include polymer particles capable of absorbing fluid such as blood. When devices of the invention are exposed to fluid, the fluid may enter the device and cause the polymer particles to swell. Devices of the invention may also apply pressure on wound cavities to stop or restrict the flow of fluid. In some embodiments, the devices may comprise components to facilitate absorption of fluid throughout the device, such as wicking elements and/or multiple compartments. One or more of the devices can be placed directly in the wound cavity, or in a containment structure and then into the wound cavity.

Claims (86)

1. A hemostatic device for treating a wound, comprising:

porous outer membrane defining a first enclosure having an interior and an exterior; and

a plurality of hemostatic units contained within the interior of the first enclosure,

wherein each hemostatic unit contains a plurality of polymer particles collectively forming a polymeric mass configured to swell in the presence of a fluid, and wherein each hemostatic unit is individually surrounded by and contained within at least one porous inner membrane forming a second enclosure that has an interior containing the plurality of polymer particles.

2. The device of claim 1 , wherein each hemostatic unit further comprises means for facilitating transport of fluid into an interior region of the polymeric mass.

3. The device of claim 2 , wherein the means for facilitating transport of fluid comprises wicking elements.

4. The device of claim 3 , wherein the wicking elements comprise wicking fibers.

5. The device of claim 4 , wherein the wicking fibers each have a diameter in the range of 10-150 microns.

6. The device of claim 3 , wherein at least a portion of the plurality of polymer particles are bonded to the wicking elements.

7. The device of claim 2 , wherein the means for facilitating transport of fluid comprises a hydrophilic material.

8. The device of claim 2 , wherein the means for facilitating transport of fluid comprises means for increasing the area for fluid flow within the enclosure.

9. The device of claim 1 , wherein the polymer particles are bonded to an inner surface of the inner membrane.

10. The device of claim 9 , wherein the polymer particles are bonded to the interior surface of the inner membrane using a surfactant and/or water-soluble adhesive.

11. The device of claim 1 , wherein the polymer particles are bonded to a strip of material located in the enclosure.

12. The device of claim 11 , wherein the polymer particles are bonded to the strip of material using a surfactant and/or water-soluble adhesive.

13. The device of claim 1 , wherein at least one of the porous outer and inner membranes is a microporous membrane.

14. The device of claim 1 , wherein the polymer particles comprise polyacrylates.

15. The device of claim 1 , wherein the polymer particles comprise sodium polyacrylate.

16. The device of claim 1 , wherein the polymer particles comprise poly-anionic beads.

17. The device of claim 1 , wherein at least one of the porous outer and inner membranes is formed of an elastic material.

18. The device of claim 1 , wherein at least one of the porous outer and inner membranes is formed of nylon, a copolymer of polyurethane and polyethlyene glycol, polyethylene terephthalate, and/or polypropylene.

19. The device of claim 1 , wherein at least one of the porous outer and inner membranes comprises pores having an average pore size of 0.15 mm to 1.0 mm.

20. The device of claim 1 , wherein at least one of the porous outer and inner membranes comprises pores having an average pore size of 0.2 mm to 0.5 mm.

21. The device of claim 1 , wherein the device is sized and configured to be inserted directly into a wound cavity.

22. The device of claim 1 , wherein the fluid comprises blood.

23. The device of claim 1 , further comprising a bonding agent.

24. A hemostatic device for treating a wound, comprising:

a first porous membrane and a second porous membrane, the first porous membrane and the second porous membrane being sealed together at discrete locations to form a plurality of compartments, each compartment forming an enclosure comprising a hemostatic unit that has an interior and an exterior,

wherein each hemostatic unit contains a plurality of polymer particles within the interior or the compartment, the particles collectively forming a polymeric mass configured to swell in the presence of a fluid.

25. The device of claim 24 , wherein each hemostatic unit further comprises means for facilitating transport of fluid into an interior region of the polymeric mass.

26. The device of claim 25 , wherein the means for facilitating transport of fluid comprises wicking elements.

27. The device of claim 26 , wherein the wicking elements comprise wicking-fibers.

28. The device of claim 27 , wherein the wicking fibers each have a diameter in the range of 10-150 microns.

29. The method of claim 25 , wherein the means for facilitating transport of fluid comprises means for increasing the area for fluid flow within the enclosure.

30. The method of claim 26 , wherein at least a portion of the plurality of polymer particles are bonded to at least a portion of the wicking elements.

31. The device of claim 25 , wherein the means for facilitating transport of fluid comprises a hydrophilic material.

32. The device of claim 24 , wherein the polymer particles comprise polyacrylates.

33. The device of claim 32 , wherein the polymer particles comprise sodium polyacrylate.

34. The device of claim 24 , wherein the polymer particles are bonded to an inner surface of at least one of the first and second membrane.

35. The device of claim 34 , wherein the polymer particles are bonded to the interior surface of the membrane using a surfactant and/or water-soluble adhesive.

36. The device of claim 24 , wherein at least one of the first and second porous membranes is a microporous membrane.

37. The device of claim 24 , wherein the polymer particles comprise poly-anionic beads.

38. The device of claim 24 , wherein at least one of the first and second porous membranes is formed of an elastic material.

39. The device of claim 24 , wherein at least one of the first and second porous membranes is formed of nylon, a copolymer of polyurethane and polyethlyene glycol, polyethylene terephthalate, and/or polypropylene.

40. The device of claim 24 , wherein at least one of the first and second porous membranes comprises pores having an average pore size of 0.15 mm to 1.0 mm.

41. The device of claim 24 , wherein at least one of the first and second porous membranes comprises pores having an average pore size of 0.2 mm to 0.5 mm.

42. The device of claim 24 , wherein the device is sized and configured to be inserted directly into a wound cavity.

43. The device of claim 24 , wherein the fluid comprises blood.

44. A hemostatic device for treating a wound, comprising:

at least one porous membrane forming at least one enclosure having an interior and an exterior;

a plurality of absorbent polymer particles contained in the interior of the enclosure, the polymer particles collectively forming a polymeric mass and being configured to swell in the presence of a fluid; and

means for facilitating transport of fluid into an interior region of the polymeric mass.

45. The device of claim 44 , wherein the means for facilitating transport of fluid comprises wicking elements.

46. The device of claim 45 , wherein the wicking elements comprise wicking-fibers.

47. The device of claim 46 , wherein the wicking-fibers each have a diameter in the range of 10-150 microns.

48. The device of claim 45 , wherein at least a portion of the plurality of absorbent polymer particles are bonded to at least a portion of the plurality of wicking elements.

49. The device of claim 44 , wherein the polymer particles are bonded to an interior surface of the porous membrane.

50. The device of claim 49 , wherein the polymer particles are bonded to the interior surface of the porous membrane using a surfactant and/or water-soluble adhesive.

51. The device of claim 44 , wherein the polymer particles are bonded to a strip of material located in the enclosure.

52. The device of claim 51 , wherein the polymer particles are bonded to a strip of material located in the enclosure using a surfactant and/or water-soluble adhesive.

53. The device of claim 44 , wherein the at least one porous membrane comprises a first membrane and a second membrane, the first membrane and the second membrane sealed together to form the enclosure.

54. The device of claim 44 , wherein the porous membrane is a microporous membrane.

55. The device of claim 44 , wherein the polymer particles comprise polyacrylates.

56. The device of claim 44 , wherein the polymer particles comprise sodium polyacrylate.

57. The device of claim 44 , wherein the polymer particles comprise poly-anionic beads.

58. The device of claim 44 , wherein the means for facilitating transport of fluid comprises a hydrophilic material.

59. The device of claim 44 , wherein the porous membrane is formed of an elastic material.

60. The device of claim 44 , wherein the porous membrane is formed of nylon, a copolymer of polyurethane and polyethlyene glycol, polyethylene terephthalate, and/or polypropylene.

61. The device of claim 44 , wherein the porous membrane comprises pores having an average pore size of 0.15 mm to 1.0 mm.

62. The device of claim 44 , wherein the porous membrane comprises pores having an average pore size of 0.2 mm to 0.5 mm.

63. The device of claim 44 , wherein the device is configured and sized to be inserted directly into a wound cavity.

64. The device of claim 44 , wherein the fluid comprises blood.

65. The device of claim 44 , further comprising a bonding agent.

66. The device of claim 44 , wherein the means for facilitating transport of fluid comprises means for increasing the area for fluid flow within the enclosure.

67. A method of treating a wound, comprising:

inserting a hemostatic device into a wound cavity,

wherein the hemostatic device contains a plurality of polymer particles within at least one enclosure formed by one or more porous membranes, the polymer particles collectively forming a polymeric mass configured to swell in the presence of a fluid, the hemostatic device further containing means for facilitating transport of fluid into an interior region of the polymeric mass.

68. The method of claim 67 , wherein the means for facilitating transport of fluid comprises wicking elements.

69. The method of claim 68 , wherein at least a portion of the plurality of polymer particles are bonded to at least a portion of the wicking elements.

70. The method of claim 67 , wherein the device is inserted directly into a wound cavity.

71. The method of claim 67 , wherein the device is inserted into a wound cavity together with additional devices.

72. The method of claim 67 , wherein the fluid comprises blood.

73. The method of claim 67 , wherein the porous membrane comprises pores having an average pore size of 0.15 mm to 1.0 mm.

74. The method of claim 67 , wherein the porous membrane comprises pores having an average pore size of 0.2 mm to 0.5 mm.

75. The method of claim 67 , wherein the device further comprises a bonding agent.

76. The method of claim 67 , wherein the means for facilitating transport of fluid comprises means for increasing the area for fluid flow within the enclosure.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2014
From: FEG HOLDINGS, LLC
To: AURORA FLIGHT SCIENCES CORPORATION
Reel/Frame 033939/0585 →
SECURITY AGREEMENT Recorded Oct 8, 2013
From: AURORA FLIGHT SCIENCES CORPORATION; AURORA FLIGHT SCIENCES OF WEST VIRGINIA, INC.
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 031393/0527 →
RELEASE OF SECURITY INTEREST Recorded Nov 12, 2010
From: FOURTH THIRD LLC
To: AURORA FLIGHT SCIENCES CORPORATION; PAYLOAD SYSTEMS, INC.
Reel/Frame 025353/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2010
From: PAYLOAD SYSTEMS, INC.
To: FEG HOLDINGS, LLC
Reel/Frame 025144/0061 →
SUPPLEMENTAL PATENT SECURITY AGREEMENT Recorded Jan 18, 2008
From: PAYLOAD SYSTEMS, INC.
To: FOURTH THIRD LLC, AS AGENT
Reel/Frame 020387/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2007
From: DE LUIS, JAVIER; SERRA, MARCO; SUTHERLAND, TIMOTHY; SUN, LIPING
To: PAYLOAD SYSTEMS, INC.
Reel/Frame 020181/0196 →